These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10653856)

  • 1. Tuning T cell activation threshold and effector function with cross-reactive peptide ligands.
    Nicholson LB; Anderson AC; Kuchroo VK
    Int Immunol; 2000 Feb; 12(2):205-13. PubMed ID: 10653856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantigen-responsive T cell clones demonstrate unfocused TCR cross-reactivity toward multiple related ligands: implications for autoimmunity.
    Anderson AC; Waldner H; Turchin V; Jabs C; Prabhu Das M; Kuchroo VK; Nicholson LB
    Cell Immunol; 2000 Jun; 202(2):88-96. PubMed ID: 10896768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autopathogenic T helper cell type 1 (Th1) and protective Th2 clones differ in their recognition of the autoantigenic peptide of myelin proteolipid protein.
    Das MP; Nicholson LB; Greer JM; Kuchroo VK
    J Exp Med; 1997 Sep; 186(6):867-76. PubMed ID: 9294141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expansion by self antigen is necessary for the induction of experimental autoimmune encephalomyelitis by T cells primed with a cross-reactive environmental antigen.
    Carrizosa AM; Nicholson LB; Farzan M; Southwood S; Sette A; Sobel RA; Kuchroo VK
    J Immunol; 1998 Oct; 161(7):3307-14. PubMed ID: 9759846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire.
    Kuchroo VK; Anderson AC; Waldner H; Munder M; Bettelli E; Nicholson LB
    Annu Rev Immunol; 2002; 20():101-23. PubMed ID: 11861599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis.
    Nicholson LB; Greer JM; Sobel RA; Lees MB; Kuchroo VK
    Immunity; 1995 Oct; 3(4):397-405. PubMed ID: 7584131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heteroclitic proliferative responses and changes in cytokine profile induced by altered peptides: implications for autoimmunity.
    Nicholson LB; Waldner H; Carrizosa AM; Sette A; Collins M; Kuchroo VK
    Proc Natl Acad Sci U S A; 1998 Jan; 95(1):264-9. PubMed ID: 9419364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental allergic encephalomyelitis mediated by cloned T cells specific for a synthetic peptide of myelin proteolipid protein. Fine specificity and T cell receptor V beta usage.
    Kuchroo VK; Sobel RA; Laning JC; Martin CA; Greenfield E; Dorf ME; Lees MB
    J Immunol; 1992 Jun; 148(12):3776-82. PubMed ID: 1376341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell tolerance induced by cross-reactive TCR ligands can be broken by superagonist resulting in anti-inflammatory T cell cytokine production.
    Illés Z; Waldner H; Reddy J; Bettelli E; Nicholson LB; Kuchroo VK
    J Immunol; 2005 Aug; 175(3):1491-7. PubMed ID: 16034086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An epitope from Acanthamoeba castellanii that cross-react with proteolipid protein 139-151-reactive T cells induces autoimmune encephalomyelitis in SJL mice.
    Massilamany C; Steffen D; Reddy J
    J Neuroimmunol; 2010 Feb; 219(1-2):17-24. PubMed ID: 20005578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of experimental allergic encephalomyelitis by myelin proteolipid-protein-specific T cell clones and synthetic peptides.
    Kuchroo VK; Sobel RA; Yamamura T; Greenfield E; Dorf ME; Lees MB
    Pathobiology; 1991; 59(5):305-12. PubMed ID: 1716908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the strength of co-stimulation through the B7/CD28 pathway alter functional T cell responses to altered peptide ligands.
    Murtaza A; Kuchroo VK; Freeman GJ
    Int Immunol; 1999 Mar; 11(3):407-16. PubMed ID: 10221652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presentation of a T cell receptor antagonist peptide by immunoglobulins ablates activation of T cells by a synthetic peptide or proteins requiring endocytic processing.
    Legge KL; Min B; Potter NT; Zaghouani H
    J Exp Med; 1997 Mar; 185(6):1043-53. PubMed ID: 9091578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen-specific CD4+ effector T cells: analysis of factors regulating clonal expansion and cytokine production: clonal expansion and cytokine production by CD4+ effector T cells.
    Ohnuki K; Watanabe Y; Takahashi Y; Kobayashi S; Watanabe S; Ogawa S; Kotani M; Kozono H; Tanabe K; Abe R
    Biochem Biophys Res Commun; 2009 Mar; 380(4):742-7. PubMed ID: 19338745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender differences in CNS autoimmunity induced by mimicry epitope for PLP 139-151 in SJL mice.
    Massilamany C; Thulasingam S; Steffen D; Reddy J
    J Neuroimmunol; 2011 Jan; 230(1-2):95-104. PubMed ID: 20950867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis.
    Kuchroo VK; Martin CA; Greer JM; Ju ST; Sobel RA; Dorf ME
    J Immunol; 1993 Oct; 151(8):4371-82. PubMed ID: 7691946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting the effects of potentially therapeutic modified peptides on polyclonal T cell populations in a mouse model of multiple sclerosis.
    Sauer EL; Trifilieff E; Greer JM
    J Neuroimmunol; 2017 Jun; 307():18-26. PubMed ID: 28495132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunopathology of acute experimental allergic encephalomyelitis induced with myelin proteolipid protein. T cell receptors in inflammatory lesions.
    Sobel RA; Kuchroo VK
    J Immunol; 1992 Aug; 149(4):1444-51. PubMed ID: 1380045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TCR agonist and antagonist exert in vivo cross-regulation when presented on Igs.
    Legge KL; Min B; Cestra AE; Pack CD; Zaghouani H
    J Immunol; 1998 Jul; 161(1):106-11. PubMed ID: 9647213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictable TCR antigen recognition based on peptide scans leads to the identification of agonist ligands with no sequence homology.
    Hemmer B; Vergelli M; Gran B; Ling N; Conlon P; Pinilla C; Houghten R; McFarland HF; Martin R
    J Immunol; 1998 Apr; 160(8):3631-6. PubMed ID: 9558061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.